Pursuant to section 35(1)(b) of the Medicines Act 1981, the Minister of Health hereby suspends consent to the distribution in New Zealand of the following medicines for a period of one year from 15 May 2014:
Schedule
Product: Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 84.869mg equivalent to Venlafaxine 75mg
Dosage Form: Modified release capsule
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Wockhardt Limited, Maharashatra State, India
Product: Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 169.738mg equivalent to Venlafaxine 150mg
Dosage Form: Modified release capsule
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Wockhardt Limited, Maharashatra State, India
Dated this 7th day of May 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister
of Health on 11 September 2013).